Vimarsana
Biggest News Aggregation in the World

Otl 200 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Otl 200. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Otl 200 Today - Breaking & Trending Today

Kyowa acquiring gene therapy firm Orchard for up to $478M - Vimarsana News

Kyowa acquiring gene therapy firm Orchard for up to $478M

Japanese specialty global pharma Kyowa Kirin Co. Ltd. has agreed to buy out Orchard Therapeutics plc in a $387.4 million cash takeover that could jump $90 million to reach $477.6 million, contingent on the pending U.S. FDA approval of its EU-approved gene therapy, Libmeldy (atidarsagene autotemcel).

Kyowa acquiring gene therapy firm Orchard for up to $478M - Vimarsana News

Kyowa acquiring gene therapy firm Orchard for up to $478M

Japanese specialty global pharma Kyowa Kirin Co. Ltd. has agreed to buy out Orchard Therapeutics plc in a $387.4 million cash takeover that could jump $90 million to reach $477.6 million, contingent on the pending U.S. FDA approval of its EU-approved gene therapy, Libmeldy (atidarsagene autotemcel).

Orchard Therapeutics Says FDA Accepts BLA For OTL-200 In Metachromatic Leukodystrophy - Vimarsana News

Orchard Therapeutics Says FDA Accepts BLA For OTL-200 In Metachromatic Leukodystrophy

Orchard Therapeutics (ORTX), a global gene therapy leader, announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the filing of its Biologics License Application (BLA) for OTL-200 in metachromatic leukodystrophy (MLD) under Priority Review.